Clinical Practice Guideline for Primary and Secondary Prevention of Stroke.

Full Version

  1. Introduction
  2. Scope and Objectives
  3. Methodology
  4. Vascular Risk
  5. Etiological Clasification of Stroke
  6. Primary Prevention of Stroke
  7. Secondary Prevention of Stroke
  8. Dissemination and Implementation
  9. Recommendations for Future Research
  10. Annexes
  11. Bibliography
  12. Full list of tables and figures

Abre nueva ventana: Section 01 in pdf version
Download Section 01 (393 Kb)

1. Introduction

 

Global magnitude of the problem

Cerebrovascular diseases or stroke, understood as circulatory brain disorders that momentarily or permanently alter the functioning of the brain, are one of the leading causes of morbimortality in the world. They are also a leading cause of permanent disability, which greatly impacts families and the community1. Cerebrovascular diseases or stroke are ranked third worldwide as the most frequent causes of death in developed countries, following coronary disease and cancer. They are also the most important cause of long-term morbidity and disability in Europe, leading to significant economic burden2.

It is calculated that in 2007, 59 million people died worldwide and that cerebrovascular diseases were the cause of death in 10% of these cases and the cause of disability in many other millions of cases3,4. Hence, prevention is preferable to treatment5. The implementation of interventions that reduce hypertension, promote a healthier diet and encourage smoking cessation could avoid more deaths than all thrombolytic, antiaggregant and neuroprotective treatments combined5.

Magnitude of the problem in our setting

There are few studies on the incidence of stroke in Spain and those that do exist present some limitations. Similarly to what has been observed in Europe6, studies demonstrate geographic variability7-10. In a study conducted in Catalonia in the year 2002, the cerebrovascular mortality rate for every 100,000 inhabitants aged 24 years and older was 92 in men and 119 in women. Age-adjusted mortality rates were 58 (95% CI: 56 to 128) and 43 (95% CI: 41 to 44), respectively11. Accumulated incidence (fatal and non-fatal cases) per 100,000 inhabitants was 218 (95% CI: 214 to 221) in men and 127 (95% CI: 125 to 128) in women. Previous data derived from a study conducted in Segovia (150 new cases per 100,000 inhabitants)12 reported somewhat lower incidences.

75% of strokes affect patients over the age of 65, which, due to the ageing population in our setting, predicts increased incidence and prevalence of this health problem in the upcoming years. According to data from the hospital morbidity survey, there has been a constant increase of the total number of patients admitted to hospital with the main diagnosis of cerebrovascular disease, reaching 114,498 cases in 2003. However, this increase does not seem to be explained solely by population growth13.

The distribution of mortality due to cerebrovascular disease in the different autonomous communities during the period spanning from 1999-2002 shows that it was higher in women than in men. In contrast, age-standardised rates were similar for both sexes, although they were higher in women in Extremadura and Galicia. The highest mortality rates due to cerebrovascular disease, both in men and women, were reported in Andalusia and Murcia14. In both cerebrovascular diseases and ischemic cardiopathy, a pronounced North-South gradient is observed (Figure 1)16. In the southern part of Spain the mortality rate due to these diseases is greater than the country’s total average, whereas the northern regions are below this average.

However, Spain is one of the countries with the lowest mortality in both men and women when compared with northern European countries such as the Netherlands, Switzerland, Ireland, Iceland and Nordic countries1.

Population strategies

The most prevalent pathologies that entail a significant health care, family and social burden are receiving special attention from specialised international organisations in all countries. In developed countries, particularly in the case of chronic pathologies, they are affecting an increasing number of people over increasingly longer periods of time, and, if not properly prevented and treated, they can lead to significant losses in patient autonomy, resulting in a considerable burden for care givers15.

The experience in several developed countries shows that by performing of a small number of interventions maintained over time it is possible to reduce the risk of death due to stroke. For example, during the 90s death rates due to stroke in our setting decreased 4% annually, as occurred in Australia, Germany, Italy or South Korea3.

At present, the Ministry of Health and Consumer Affairs (MSC) has launched a campaign on healthy habits with the aim of promoting lifestyles and eating habits that favour citizens’ health and well-being. The main objective of this campaign is to encourage healthy habits and lifestyles to prevent the development of vascular diseases. This campaign includes, amongst its main objectives: to increase society’s awareness and mobilisation to generate a culture that works to prevent vascular diseases via the management of the main risk factors; to promote healthy lifestyles and manage risk factors with the aim of significantly reducing the incidence of vascular diseases in the general population, in healthy people as well as in those who have suffered some type of vascular disease; to increase awareness of the population with vascular disease and risk factors on the importance of becoming involved and being responsible for the management of their disease, following the recommendations and monitoring provided by health care professionals and follow-up of pharmacological treatment and, finally, promoting a culture of healthy habits: physical exercise, a low-fat, low-salt diet low and smoking cessation.

Figure 1: Map of mortality due to cerebrovascular disease in Spain, 1989-199616

 

Map of mortality

Adapted from: López-Abente G, Ramis R, Pollán M, Aragonés N, Pérez-Gómez B, Gómez-Barroso D, et al. Atlas municipal de mortalidad por cáncer en España, 1989-1998. Madrid (Spain): Carlos III Institute of Health; 2006.

CEREBROVASCULAR DISEASE (ICD 430-438)
Both sexes 1989-1998
Smoothed relative risk
Smoothed RR (Number of municipalities)


arriba

Section 01 Bibliography


  1. 1. World Health Organization, Preventing chronic diseases: a vital investment; 2005 [consulted on 19 March 2008]. Available at: http://www.who.int/chp/chronic_disease_report/full_report.pdf Abre nueva ventana
  2. 2. The European Stroke Initiative Committee and the EUSI Writing Committee. European Stroke Initiative Recommendations for Stroke Management. Update 2003. Cerebrovasc Dis. 2003;16:311-337.
  3. 3. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007; 6(2):182-7.
  4. 4. Horton R. Chronic diseases: the case for urgent global action. Lancet. 2007; 370(9603):1881-2.
  5. 5. Stroke—prevention is better than cure. Lancet. 2007;369:247.
  6. 6. Wolfe CD, Giroud M, Kolomisky-Rabas P, Dundas R, Lemesle M, Heuschmann P, et al. Variations in stroke incidence and survival in 3 areas of Europe. European Registries of Stroke (EROS) Collaboration. Stroke. 2000;31(9):2074-9.
  7. 7. López-Pousa S, Vilalta J, Llinás J. Incidencia de la enfermedad vascular cerebral en España: estudio en un área rural de Girona. Rev Neurol. 1995;23:1074-80.
  8. 8. Caicoya M, Rodríguez T, Lasheras C, Cuello R, Corrales C, Blázquez B. Incidencia del accidente cerebrovascular en Asturias: 1990-1991. Rev Neurol. 1996;24:806-11.
  9. 9. Díaz-Guzmán J, Egido J, Abilleira S, Barberá G, Gabriel R, en representación del grupo Proyecto Ictus (GEECV) de la Sociedad Española de Neurología. Incidencia del ictus en España: datos preliminares crudos del estudio Iberictus. Neurología. 2007;22(9):605. 1
  10. 10. Aymerich N, Zandio B, Martín M, Muruzábal J, Delgado G, Gállego J, et al. Incidencia de ictus y mortalidad precoz en la comarca de Pamplona. Neurología. 2007;22(9):603.
  11. 11. Marrugat J, Arboix A, García-Eroles L, Salas T, Vila J, Castell C, et al. The estimated incidence and case fatality rate of ischemic and hemorrhagic cerebrovascular disease in 2002 in Catalonia. Rev Esp Cardiol. 2007; 60(6):573-80.
  12. 12. Sempere AP, Duarte J, Cabezas C, Clavería LC. Incidence of transient ischemic attacks and minor ischemic strokes in Segovia, Spain. Stroke. 1996;27:667-71.
  13. 13. Encuesta Nacional de Morbilidad Hospitalaria. INE 2005. [consulted on 19 March 2008]. Available at: http://www.ine.es Abre nueva ventana.
  14. 14. Ministerio de Sanidad y Consumo. Estrategia en Cardiopatía Isquémica del Sistema Nacional de Salud. Madrid (España): Ministerio de Sanidad y Consumo; Centro de Publicaciones; 2006.
  15. 15. [Informe MSC Desigualdades 2006] Desigualdades de mortalidad en las comunidades autónomas entre 1981 y 2002. Observatorio de Salud de la Mujer. Dirección General de la Agencia de Calidad del Sistema Nacional de Salud. Secretaría General de Sanidad. Ministerio de Sanidad y Consumo; 2006.
  16. 16. López-Abente G, Ramis R, Pollán M, Aragonés N, Pérez-Gómez B, Gómez-Barroso D, et al. Atlas municipal de mortalidad por cáncer en España, 1989-1998. Madrid (España): Instituto de Salud Carlos III; 2006.

Figures and Tables

Figure 1. Map of mortality due to cerebrovascular disease in Spain, 1989-1996 Abrir nueva ventana (pdf, 256 Kb.)

Latest update: Enero 2009

Logo del Ministerio de Sanidad y Consumo Logo del Plan de Calidad del Sistema Nacional de SaludAgència d’Avaluació de Tecnologia i Recerca Mèdiques de Cataluña

 

Copyright | Help | Map